Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs ReadyRx

Boston Medical Group
Graded #113

Higher grade

vs+2.3000000000000114
ReadyRx
Graded #168

Lower grade

The verdict

Boston Medical Group takes it — 69.9/100 to 67.6/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +26
86
60
Dose & formulationReadyRx +12
52
64
Clinical oversightBoston Medical Group +10
89
79
Labs & monitoringReadyRx +11
53
64
FulfillmentReadyRx +18
65
83
Contract termsEven
55
55
Boston Medical Group · left barReadyRx · right bar

The numbers

MetricBoston Medical GroupReadyRx
WeighScore69.9/10067.6/100
GradeCC
Scorecard rank#113#168
Semaglutide$66/mo (starting dose, compounded)$179/mo (starting dose, compounded)
TirzepatideNot disclosed$255/mo (starting dose, compounded)
Coverage7 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
ReadyRx

Graded #168 · C

Strengths

  • LegitScript Certified — verifiable via the badge link in the footer
  • Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
  • Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide

Where it loses points

  • Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
  • Clinicians described as licensed and board-certified, but no names or credentials published
  • 5,000+ member figure comes from a directory listing, not an independent audit

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard